• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lixte Biotechnology Holdings, Inc. - Common Stock (NQ:LIXT)

7.190 +0.540 (+8.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lixte Biotechnology Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
InvestorNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Joins Russell Microcap(R) Index
Today 10:27 EDT
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch
June 18, 2026
From World Street Intelligence
Via GlobeNewswire
MissionIRNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances NOMAD Acquisition, Provides $6.5 Million Pre-Closing Loan
June 18, 2026
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
The AI Boom’s Real Bottleneck Is Power — and One Nasdaq Company Is Reinventing Itself to Solve It
June 18, 2026
From USA News Group
Via GlobeNewswire
MissionIRNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) to Acquire Mobile Energy Storage Provider NOMAD
June 12, 2026
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
The New Bottleneck Isn’t Computing Power — It’s Just Power
June 12, 2026
From Equity Insider
Via GlobeNewswire
TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Prices $16.6 Million Registered Direct Offering
June 03, 2026
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Shifts Focus to AI Energy Infrastructure, Adds Denham Capital Founder to Board
June 01, 2026
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
InvestorNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Reports First-Quarter Progress on Oncology Pipeline and Strategic Expansion
May 15, 2026
Via Investor Brand Network
Topics Intellectual Property
TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Unlocking New Potential in Precision Cancer Treatment
April 24, 2026
Via Investor Brand Network
Topics Intellectual Property
MissionIRNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape
April 17, 2026
Via Investor Brand Network
Topics Intellectual Property
Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapies Are Built
April 17, 2026
Via Investor Brand Network
Compact Proton Therapy Delivery Helps Make the Treatment More Accessible for Cancer Patients
April 15, 2026
Via Investor Brand Network
BioMedNewsBreaks — LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference
April 13, 2026
Via Investor Brand Network
Topics Intellectual Property
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Accelerates Cancer Care Innovation with Liora Technologies Acquisition and Leadership Expansion
April 10, 2026
Via Investor Brand Network
Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships
April 09, 2026
Via Investor Brand Network
MissionIRNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Files 2025 Form 10-K, Highlights Transformational Year
April 01, 2026
Via Investor Brand Network
Topics Intellectual Property
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes
March 31, 2026
Via Investor Brand Network
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials
March 30, 2026
Via Investor Brand Network
Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership
March 26, 2026
Via Investor Brand Network
Landmark Proton Therapy Data Changes the Conversation; LIXTE Saw It Coming
March 24, 2026
Via Investor Brand Network
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape
March 20, 2026
Via Investor Brand Network
Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy
March 16, 2026
Via Investor Brand Network
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships
March 13, 2026
Via Investor Brand Network
Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy
March 09, 2026
Via Investor Brand Network
TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline
March 06, 2026
Via Investor Brand Network
Topics Intellectual Property
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances Lead Compound in Tumor Immunogenicity Research
March 06, 2026
Via Investor Brand Network
Liora, a subsidiary of LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), Introduces New CEO, Brings Experience to Treating Tumors with Proton Therapy
March 02, 2026
Via Investor Brand Network
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands into Proton Therapy Through Liora Technologies, Advancing the LiGHT System for Next-Generation Cancer Care
February 23, 2026
Via Investor Brand Network
BioMedNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary
February 18, 2026
Via Investor Brand Network
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap